{
    "Trade/Device Name(s)": [
        "Precision Xceed Pro Blood Glucose and \u03b2-Ketone Monitoring System"
    ],
    "Submitter Information": "Abbott Diabetes Care Inc.",
    "510(k) Number": "K080960",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040814"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JIN"
    ],
    "Summary Letter Date": "August 14, 2008",
    "Summary Letter Received Date": "August 15, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1435"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Ketones test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose",
        "\u03b2-Ketone",
        "Beta-hydroxybutyrate"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonatal whole blood"
    ],
    "Specimen Container(s)": [
        "Precision Xceed Pro test strips",
        "Precision Control Solution",
        "MediSense Control Solution",
        "Optium Control Solution"
    ],
    "Instrument(s)/Platform(s)": [
        "Precision Xceed Pro Blood Glucose and \u03b2-Ketone Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor",
        "Electrochemical measurement"
    ],
    "Methodologies": [
        "Enzyme-based electrochemical detection"
    ],
    "Submission Type(s)": [
        "Monitoring System"
    ],
    "Document Summary": "FDA 510(k) summary for Precision Xceed Pro system for quantitative measurement of glucose and \u03b2-ketone in whole blood using amperometric biosensor technology",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary, venous, arterial, and neonatal whole blood, and \u03b2-ketone in fresh capillary and venous whole blood, as an aid in monitoring effectiveness of diabetes control programs for home or professional use",
    "fda_folder": "Clinical Chemistry"
}